GLX2-4 Antibody

Shipped with Ice Packs
In Stock

Description

Target Overview: Glutathione Peroxidase 4 (GPX4)

GPX4 is a selenium-dependent enzyme that protects cells from oxidative damage by reducing lipid hydroperoxides, thereby preventing ferroptosis—a form of regulated cell death driven by iron-dependent lipid peroxidation .

PropertyDescription
GeneGPX4 (Homo sapiens)
Molecular Weight~22 kDa (predicted); observed ~20 kDa in Western blot
FunctionAntioxidant defense, ferroptosis suppression
Cellular LocalizationCytoplasm, mitochondria, nucleus

Anti-GPX4 Antibody [EPNCIR144] (ab125066)

This rabbit monoclonal antibody is widely used in research due to its specificity and validation across multiple platforms .

Key Features

  • Applications: Western blotting (WB), immunohistochemistry (IHC), immunofluorescence (IF), flow cytometry (FC) .

  • Species Reactivity: Human, mouse, rat.

  • Validation:

    • Knockout Control: Tested in GPX4-knockout HeLa cells (ab262509) .

    • Tissue Specificity: Confirmed in human kidney, HEK293, and HeLa cells .

Performance Data

ApplicationDilutionSampleResult
Western Blot1:20,000Human GPX4 knockout HeLa lysateNo band observed (specificity confirmed)
IHC1:100Paraffin-embedded human kidneyStrong cytoplasmic staining
Flow Cytometry1:400HeLa cells (permeabilized)Positive intracellular signal

Research Implications

GPX4 antibodies are pivotal in studying:

  1. Ferroptosis Mechanisms: GPX4 inhibition leads to lipid peroxidation cascades, making it a therapeutic target in cancer .

  2. Neurological Disorders: Oxidative stress mitigation in diseases like Parkinson’s .

  3. Antibody-Dependent Pathologies: IgG4 subclass antibodies (e.g., in autoimmune diseases) may interfere with GPX4 signaling .

Comparative Analysis of IgG Subclasses in Antibody Design

GPX4 antibodies are typically IgG1 or IgG4 subclasses, influencing effector functions:

PropertyIgG1IgG4
Effector FunctionStrong (ADCC, CDC)Weak (anti-inflammatory)
Half-Life~21 days~21 days
Fab Arm ExchangeNoYes (monovalent binding)
Therapeutic UseOncology, infectionsAllergy, autoimmune diseases

Validation and Challenges

  • Cross-Reactivity: Tissue cross-reactivity studies (e.g., Source ) are critical to ensure specificity, as off-target binding could confound results.

  • Glycosylation Impact: Altered glycosylation patterns in IgG4 may reduce complement activation, affecting therapeutic efficacy .

Future Directions

  • Engineered GPX4 Antibodies: Fc region modifications to enhance half-life or tissue penetration .

  • Clinical Trials: Targeting GPX4 in ferroptosis-prone cancers (e.g., glioblastoma) .

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
14-16 weeks lead time (made-to-order)
Synonyms
GLX2-4 antibody; At1g06130 antibody; T21E18.18Probable hydroxyacylglutathione hydrolase 2 antibody; chloroplastic antibody; EC 3.1.2.6 antibody; Glyoxalase 2-4 antibody; Glyoxalase II antibody; Glx II antibody
Target Names
GLX2-4
Uniprot No.

Target Background

Function
A thiolesterase enzyme. Its function is the hydrolysis of S-D-lactoyl-glutathione to yield glutathione and D-lactic acid.
Database Links

KEGG: ath:AT1G06130

STRING: 3702.AT1G06130.1

UniGene: At.26891

Protein Families
Metallo-beta-lactamase superfamily, Glyoxalase II family
Subcellular Location
Plastid, chloroplast.

Q&A

What is GLX2-4 and what biological role does it play in plants?

GLX2-4 (Glyoxalase 2-4) is one of five glyoxalase 2 isoforms found in Arabidopsis thaliana and belongs to the metallo-β-lactamase family. It functions as a hydroxyacylglutathione hydrolase in the second step of the glyoxalase pathway, catalyzing the hydrolysis of S-D-lactoylglutathione to D-lactic acid while regenerating glutathione . GLX2-4 is primarily localized in the mitochondria, along with GLX2-1 and GLX2-5, though its precise subcellular distribution may vary under different conditions .

The glyoxalase system plays a crucial role in protecting plants against methylglyoxal toxicity, particularly during stress conditions when reactive α-oxoaldehydes accumulate. Within this system, GLX2-4 contributes to maintaining cellular redox balance and preventing the accumulation of potentially harmful metabolites, thereby supporting plant survival under adverse environmental conditions .

What detection methods are compatible with GLX2-4 antibody?

Based on standard antibody applications, GLX2-4 antibody can be utilized in multiple detection methods including:

  • Western blotting (WB): For quantitative analysis of GLX2-4 expression levels

  • Immunoprecipitation (IP): To isolate GLX2-4 protein and identify interaction partners

  • Immunofluorescence (IF): For subcellular localization studies

  • Enzyme-linked immunosorbent assay (ELISA): For quantitative detection in complex samples

The GLX2-4 antibody may be available in various conjugated forms, including horseradish peroxidase (HRP), phycoerythrin (PE), fluorescein isothiocyanate (FITC), and Alexa Fluor® conjugates, enabling diverse detection strategies depending on experimental requirements . When working with plant samples, special consideration should be given to extraction protocols to ensure efficient recovery of mitochondrial proteins where GLX2-4 is primarily localized.

How do the different GLX2 isoforms in Arabidopsis thaliana differ from each other?

Arabidopsis thaliana possesses five identified GLX2 genes, each encoding distinct isoforms with varying properties:

IsoformSubcellular LocalizationFunctional PropertiesExpression Pattern
GLX2-1MitochondrialLacks glyoxalase activity but possesses β-lactamase activity; essential during abiotic stressUpregulated during stress conditions
GLX2-2UnknownFunctional role not fully characterizedTissue-specific expression
GLX2-3UnknownFunctional role not fully characterizedTissue-specific expression
GLX2-4MitochondrialActive glyoxalase 2Expression patterns not fully characterized
GLX2-5MitochondrialActive glyoxalase 2, shows high similarity (88%) to GLX2-1Constitutively expressed

Research indicates that some GLX2 isoforms in Arabidopsis may be inactive as glyoxalases but possess alternative enzymatic functions, suggesting evolutionary diversification . The multiple GLX2 forms likely indicate tissue-specific methylglyoxal detoxification mechanisms. Notably, GLX2-1 shows high sequence similarity to GLX2-5 but has evolved β-lactamase activity instead of glyoxalase function, demonstrating functional divergence of these proteins .

How does the glyoxalase system respond to abiotic stress in plants?

The glyoxalase system in plants plays a crucial role in abiotic stress response through multiple mechanisms:

  • Detoxification of methylglyoxal (MGO): Under stress conditions, increased glycolytic flux leads to elevated MGO production, which the glyoxalase system detoxifies.

  • Coordination with antioxidant systems: The activities of glyoxalases and antioxidant defense systems are coordinated to reduce both reactive oxygen species (ROS) and MGO levels that increase during abiotic stress .

  • Transcriptional regulation: Analysis of GLX2 gene promoters has revealed the presence of stress-responsive elements including fungal elicitor-responsive element (BOX-W1), wounding-and pathogen-responsive elements (W-box and WUN-motif), and defense and stress-responsive elements (TC-rich) .

  • Tissue-specific expression: Different GLX2 isoforms, including GLX2-4, may be differentially expressed across tissues during stress, allowing for specialized responses in different plant parts.

Using GLX2-4 antibody, researchers can monitor protein expression changes in response to various stressors, correlate protein levels with enzymatic activity, and examine subcellular redistribution during stress responses.

What are the optimal protocols for Western blot detection of GLX2-4?

Optimizing Western blot protocols for GLX2-4 detection requires specific considerations given its mitochondrial localization and expression patterns:

Sample Preparation:

  • Use specialized extraction buffers containing 0.1-0.5% Triton X-100 or digitonin to effectively solubilize mitochondrial membranes.

  • Include protease inhibitors (PMSF, leupeptin, pepstatin A) to prevent degradation during isolation.

  • Consider mitochondrial enrichment via differential centrifugation for enhanced detection sensitivity.

Gel Electrophoresis:

  • Use 10-12% polyacrylamide gels for optimal separation.

  • Load 30-50 μg of total protein per lane or 10-15 μg of enriched mitochondrial fraction.

  • Include reducing agents (DTT or β-mercaptoethanol) in sample buffer to ensure proper protein denaturation.

Transfer and Detection:

  • Semi-dry transfer at 15V for 30-45 minutes or wet transfer at 30V overnight at 4°C for efficient transfer of mitochondrial proteins.

  • Block with 5% BSA in TBST (preferred over milk for phosphorylated proteins).

  • Optimal primary antibody dilution typically ranges from 1:1000 to 1:2000, incubated overnight at 4°C.

Controls:

  • Include recombinant GLX2-4 protein as a positive control.

  • Use samples from GLX2-4 knockout/knockdown plants as negative controls.

  • Employ VDAC or other mitochondrial proteins as loading controls specific for mitochondrial proteins.

Troubleshooting:

  • If multiple bands appear, test phosphatase treatment to determine if post-translational modifications affect antibody recognition.

  • For weak signals, extend primary antibody incubation time and optimize protein loading.

How can researchers validate the specificity of GLX2-4 antibody for experimental applications?

Thorough validation of GLX2-4 antibody specificity is essential for reliable experimental outcomes. A comprehensive validation approach should include:

  • Genetic validation: Compare antibody reactivity between wild-type Arabidopsis and GLX2-4 knockout/knockdown lines. The antibody should show significantly reduced or absent signal in plants lacking GLX2-4 expression .

  • Immunizing peptide competition: Pre-incubate the antibody with excess immunizing peptide before application. Specific binding to GLX2-4 should be blocked, resulting in signal reduction or elimination.

  • Cross-reactivity assessment: Test the antibody against recombinant proteins of all five GLX2 isoforms to evaluate potential cross-reactivity, particularly with the closely related GLX2-1 and GLX2-5 .

  • Immunoprecipitation-mass spectrometry: Perform immunoprecipitation followed by mass spectrometry to confirm that the antibody specifically pulls down GLX2-4 rather than other proteins.

  • Multiple detection methods: Confirm specificity using complementary techniques like immunohistochemistry, ELISA, and flow cytometry when applicable.

  • Recombinant protein array: Test antibody binding against a panel of recombinant proteins to assess off-target interactions, similar to approaches used for other antibody validations .

  • Expression correlation: Compare protein detection patterns with known mRNA expression profiles of GLX2-4 across tissues and conditions.

This multi-faceted validation approach should be documented thoroughly to establish confidence in experimental results using the GLX2-4 antibody.

What considerations should be made when using GLX2-4 antibody for immunolocalization studies?

Immunolocalization with GLX2-4 antibody requires special attention to several methodological aspects given its mitochondrial localization:

Fixation Protocols:

  • Use 4% paraformaldehyde with 0.1-0.5% glutaraldehyde for optimal preservation of mitochondrial structures.

  • Shorter fixation times (15-30 minutes) may preserve antigenicity better than extended fixation.

  • Consider comparing multiple fixation protocols to determine optimal epitope preservation.

Permeabilization Considerations:

  • More stringent permeabilization (0.2-0.5% Triton X-100 for 15-30 minutes) may be necessary to allow antibody access to mitochondrial proteins.

  • Test detergent concentration gradients to find the optimal balance between membrane permeabilization and structural preservation.

Co-localization Markers:

  • Always include established mitochondrial markers (MitoTracker, TOM20, cytochrome c oxidase) for co-localization studies.

  • Consider dual staining with antibodies against other GLX2 isoforms to examine potential differential localization.

Controls:

  • Include pre-immune serum controls to assess non-specific binding.

  • Use GLX2-4 knockout/knockdown plants as negative controls.

  • Perform peptide competition assays to confirm specificity of staining.

Microscopy Techniques:

  • Utilize confocal microscopy with Z-stack acquisition for accurate localization within mitochondria.

  • Consider super-resolution techniques (STED, STORM) for detailed subcellular localization.

  • For co-localization studies, carefully analyze signal overlap using appropriate statistical methods.

Sample-Specific Considerations:

  • Different plant tissues may require modified protocols due to varying cell wall composition and organelle abundance.

  • Developmental stage may affect GLX2-4 expression and localization, requiring age-matched controls.

How can GLX2-4 antibody be utilized to study post-translational modifications of the protein?

Research indicates that proteins in the glyoxalase system may undergo various post-translational modifications (PTMs) that affect their function. Several approaches can be employed to study PTMs of GLX2-4:

  • 2D-gel electrophoresis coupled with Western blotting: Separate GLX2-4 protein based on both isoelectric point and molecular weight to identify different modification states. Multiple spots detected by GLX2-4 antibody may indicate the presence of PTMs.

  • Phosphorylation analysis:

    • Use phospho-specific detection methods (Pro-Q Diamond staining) alongside GLX2-4 antibody detection.

    • Perform phosphatase treatment prior to Western blotting to determine if phosphorylation affects antibody recognition.

    • Immunoprecipitate GLX2-4 using the antibody and analyze by mass spectrometry to identify phosphorylation sites.

  • S-glutathionylation detection:

    • Given the role of glyoxalase 2 in promoting S-glutathionylation of certain target proteins , investigate whether GLX2-4 itself undergoes this modification under oxidative stress.

    • Use biotinylated glutathione to detect glutathionylated proteins followed by GLX2-4 antibody detection.

  • Acetylation studies:

    • Examine potential acetylation of GLX2-4 using anti-acetyllysine antibodies after GLX2-4 immunoprecipitation.

    • Compare acetylation status under different stress conditions that might affect the glyoxalase system .

  • Redox modifications:

    • Employ redox proteomics approaches to investigate potential oxidative modifications of cysteine residues in GLX2-4.

    • Use differential labeling of reduced and oxidized cysteines followed by GLX2-4 immunoprecipitation.

  • PTM-induced conformational changes:

    • Compare antibody recognition of native versus denatured protein to detect potential epitope masking by PTMs.

    • Analyze proteolytic digestion patterns to identify regions protected by modifications.

This multi-faceted approach can reveal how PTMs regulate GLX2-4 function, particularly under stress conditions when the glyoxalase system is most active.

What strategies can researchers employ to investigate GLX2-4 interactions with other proteins in the glyoxalase pathway?

Investigating protein-protein interactions involving GLX2-4 requires specialized approaches that maintain physiological relevance:

Co-immunoprecipitation (Co-IP):

  • Use GLX2-4 antibody conjugated to agarose or magnetic beads to pull down GLX2-4 along with interacting partners .

  • Perform reciprocal Co-IPs with antibodies against suspected interaction partners (e.g., GLX1, glutathione-related proteins).

  • Include appropriate controls: IgG control, pre-clearing steps, and validation in knockout/knockdown lines.

Proximity Labeling:

  • Genetically fuse GLX2-4 to BioID or APEX2 proximity labeling enzymes.

  • Express in plant cells to biotinylate proteins in close proximity to GLX2-4.

  • Capture biotinylated proteins and identify by mass spectrometry.

  • Validate interactions using GLX2-4 antibody in co-localization or Co-IP studies.

Bimolecular Fluorescence Complementation (BiFC):

  • Generate constructs with GLX2-4 fused to one half of a split fluorescent protein.

  • Co-express with potential interacting partners fused to the complementary half.

  • Validate observed interactions with co-IP using GLX2-4 antibody.

Analytical Size Exclusion Chromatography:

  • Fractionate plant extracts by size exclusion chromatography.

  • Analyze fractions by Western blotting with GLX2-4 antibody and antibodies against potential interacting partners.

  • Co-elution in the same fractions suggests complex formation.

Crosslinking Mass Spectrometry:

  • Treat intact plant material with membrane-permeable crosslinkers.

  • Immunoprecipitate with GLX2-4 antibody.

  • Analyze crosslinked peptides by mass spectrometry to identify direct interaction partners and interfaces.

Functional Validation:

  • Conduct enzymatic assays with purified components to assess whether interactions affect GLX2-4 activity.

  • Compare activity and interaction profiles under normal versus stress conditions.

  • Use genetic approaches (knockouts of interaction partners) to validate functional significance.

This systematic approach can reveal the protein interaction network of GLX2-4 and provide insights into its regulation and function within the glyoxalase system.

How can GLX2-4 antibody be used to investigate the role of the glyoxalase system in abiotic stress responses?

The GLX2-4 antibody provides a powerful tool for examining glyoxalase system function during stress conditions:

Expression Analysis Across Stress Conditions:

  • Compare GLX2-4 protein levels across multiple abiotic stressors (drought, salinity, heavy metals, heat, cold) using quantitative Western blot analysis.

  • Correlate GLX2-4 expression with stress severity and duration to establish dose-response relationships.

  • Examine tissue-specific expression patterns to identify primary sites of glyoxalase system activation.

Time-Course Studies:

  • Monitor temporal changes in GLX2-4 expression during stress onset, maintenance, and recovery phases.

  • Correlate protein expression kinetics with physiological and metabolic changes to establish causality.

  • Compare with other stress-responsive proteins to place GLX2-4 within the broader stress response network.

Subcellular Redistribution:

  • Use immunofluorescence with GLX2-4 antibody to track potential stress-induced changes in subcellular localization.

  • Combine with mitochondrial health markers to correlate GLX2-4 distribution with mitochondrial function.

  • Perform subcellular fractionation followed by Western blotting to quantify redistribution between compartments.

Correlation with Metabolic Changes:

  • Measure methylglyoxal and S-D-lactoylglutathione levels alongside GLX2-4 protein levels.

  • Correlate GLX2-4 expression with glutathione redox status to link protein function with cellular redox homeostasis.

  • Analyze glyoxalase enzyme activity in relation to protein abundance to identify post-translational regulation.

Comparative Analysis Across GLX2 Isoforms:

  • Examine differential expression patterns of multiple GLX2 isoforms to identify stress-specific isoform utilization.

  • Investigate potential compensatory relationships between isoforms in stress response pathways.

Genetic Validation:

  • Use GLX2-4 antibody to confirm knockout/knockdown efficiency in mutant lines.

  • Compare stress phenotypes with protein expression levels to establish structure-function relationships.

This comprehensive approach can reveal the specific contribution of GLX2-4 to plant stress tolerance mechanisms and identify potential targets for improving crop resilience.

What controls should be included when using GLX2-4 antibody in glycoprotein interaction studies?

When investigating GLX2-4 interactions with glycoproteins or glycan structures, several specialized controls should be implemented:

Antibody Specificity Controls:

  • Pre-adsorption control: Pre-incubate GLX2-4 antibody with recombinant GLX2-4 protein before immunoprecipitation to demonstrate binding specificity.

  • Isotype control: Use an irrelevant antibody of the same isotype to identify non-specific binding.

  • GLX2-4 knockout/knockdown: Perform parallel experiments with material from plants lacking GLX2-4 expression.

Glycan Specificity Controls:

  • Glycosidase treatments: Treat samples with specific glycosidases prior to immunoprecipitation to verify glycan-dependent interactions.

  • Lectin competition: Include specific lectins that bind known glycan structures to compete with potential GLX2-4-glycoprotein interactions.

  • Synthetic glycan arrays: Test GLX2-4 binding to glycan arrays to establish glycan binding profiles, similar to approaches used for anti-glycan antibodies .

Interaction Validation Controls:

  • Reciprocal co-immunoprecipitation: Confirm interactions by immunoprecipitating with antibodies against suspected glycoprotein partners.

  • Mutated glycosylation sites: Use glycoprotein variants with mutated glycosylation sites to confirm the role of specific glycans in the interaction.

  • In vitro binding assays: Perform surface plasmon resonance or bio-layer interferometry with purified components to verify direct interactions.

Technical Controls:

  • Input samples: Analyze a portion of the starting material to confirm the presence of both GLX2-4 and potential glycoprotein partners.

  • Non-specific binding controls: Include beads-only controls to identify proteins that bind non-specifically to the matrix.

  • Detergent controls: Test multiple detergent conditions to ensure interactions are not artifacts of extraction conditions.

Functional Validation:

  • Activity assays: Measure GLX2-4 enzymatic activity in the presence and absence of interacting glycoproteins.

  • Mass spectrometry validation: Confirm the identity and glycosylation status of interacting proteins.

This comprehensive control strategy will establish the specificity and biological relevance of any observed interactions between GLX2-4 and glycoproteins.

How can researchers integrate GLX2-4 antibody with other research techniques to investigate the glyoxalase system in plants?

Integrating GLX2-4 antibody with complementary techniques provides a more comprehensive understanding of the glyoxalase system:

Transcriptomic Integration:

  • Correlate GLX2-4 protein levels (detected by Western blot) with mRNA expression (RNA-seq or qRT-PCR).

  • Identify post-transcriptional regulation mechanisms by comparing RNA and protein expression kinetics.

  • Use GLX2-4 antibody to validate protein expression in transcriptome-wide studies of stress responses.

Metabolomic Connections:

  • Combine GLX2-4 protein quantification with targeted metabolite analysis of glyoxalase pathway components.

  • Correlate GLX2-4 levels with methylglyoxal, S-D-lactoylglutathione, D-lactic acid, and glutathione measurements.

  • Use immunoprecipitation with GLX2-4 antibody followed by metabolite extraction to identify metabolites associated with the protein.

Proteomic Approaches:

  • Use GLX2-4 antibody for immunoprecipitation followed by mass spectrometry to identify interaction partners.

  • Perform comparative proteomics between wild-type and GLX2-4 mutant plants to identify downstream effectors.

  • Apply PTM-specific proteomics to identify modifications of GLX2-4 and related proteins under stress conditions.

Genetic Techniques:

  • Confirm knockout/knockdown efficiency in mutant lines using GLX2-4 antibody.

  • Validate transgene expression in complementation studies.

  • Use chromatin immunoprecipitation (ChIP) with antibodies against transcription factors to study GLX2-4 gene regulation.

Imaging Technologies:

  • Combine immunofluorescence using GLX2-4 antibody with advanced microscopy techniques like FRET, FLIM, or super-resolution microscopy.

  • Perform co-localization studies with markers for different cellular compartments.

  • Use live cell imaging with fluorescently-tagged GLX2-4 antibody fragments in permeabilized cells for dynamic studies.

Enzymatic Activity Assays:

  • Correlate GLX2-4 protein levels with hydroxyacylglutathione hydrolase activity measurements.

  • Perform activity assays on immunoprecipitated GLX2-4 to assess functional state.

  • Compare activity in fractions with different modification states of GLX2-4.

This integrated approach provides a systems-level understanding of GLX2-4 function and regulation within the plant stress response network.

What factors should be considered when using Arabidopsis-derived GLX2-4 antibodies for research in other plant species?

When extending GLX2-4 antibody applications to non-Arabidopsis species, researchers should carefully evaluate several factors:

Sequence Homology Assessment:

  • Perform sequence alignment of GLX2-4 proteins across target species to predict antibody cross-reactivity.

  • Focus particularly on the epitope region recognized by the antibody.

  • Higher sequence conservation (>80%) suggests better likelihood of cross-reactivity.

Validation Strategy:

  • Perform Western blots with positive controls (Arabidopsis samples) alongside samples from target species.

  • Confirm that detected bands in the new species match the expected molecular weight based on sequence analysis.

  • Consider testing immunoprecipitation efficiency in the new species compared to Arabidopsis.

Optimization Requirements:

  • Adjust antibody concentration for different species (typically 1.5-3x higher concentrations for cross-species applications).

  • Modify extraction buffers to account for species-specific differences in cell wall composition or secondary metabolites.

  • Optimize blocking conditions to minimize background in the target species.

Confirmation Approaches:

  • Use mass spectrometry to confirm the identity of the protein detected by the antibody in the new species.

  • Perform RNA interference or CRISPR-based knockout of the GLX2-4 homolog in the target species to validate antibody specificity.

  • Consider developing species-specific antibodies for critical applications if cross-reactivity is suboptimal.

Alternative Detection Strategies:

  • For species with low cross-reactivity, consider using epitope tagging approaches instead of direct antibody detection.

  • Employ genomic approaches (promoter-reporter fusions) to complement antibody-based studies.

This careful cross-species validation ensures reliable results when extending GLX2-4 research beyond Arabidopsis.

How does the methodological approach for studying GLX2-4 in plants differ from approaches used with homologous proteins in other organisms?

Studying plant GLX2-4 requires specialized approaches compared to homologous proteins in other organisms:

Methodological AspectPlant GLX2-4 ApproachApproach in Other OrganismsKey Differences
Sample PreparationCell wall disruption required; consideration of multiple organelles; specialized buffers to handle phenolics and secondary metabolitesCell lysis with standard detergents; typically simpler extraction proceduresPlants require more aggressive extraction protocols; consideration of chloroplast autofluorescence for imaging
Subcellular FractionationFocus on mitochondrial isolation; must separate from chloroplasts and peroxisomesStandard differential centrifugation protocolsPlant mitochondrial isolation requires additional purification steps to eliminate chloroplast contamination
Genetic ManipulationHigher reliance on RNAi and overexpression; CRISPR becoming more accessibleCRISPR-based approaches well established in many systems; conditional knockouts commonPlant transformation more time-consuming; genetic redundancy more common
Protein InteractionsHigher focus on stress-responsive interaction networks; consideration of spatial isolation in different tissuesOften studied in more homogeneous cell populationsPlants require tissue-specific analyses; developmental context critical
Post-translational ModificationsGreater emphasis on stress-induced modifications; redox regulation particularly importantGeneral PTM profiling approaches similarPlants have unique stress-responsive PTM patterns; different PTM enzymes
Activity AssaysNeed to account for multiple GLX2 isoforms with potentially overlapping activitiesOften simpler systems with fewer isoformsPlants require careful isoform discrimination; activity measurements more complex

These differences highlight the need for specialized approaches when studying GLX2-4 in plants compared to glyoxalase homologs in other organisms. Understanding these methodological distinctions ensures appropriate experimental design and interpretation of results across different biological systems .

What are common challenges in GLX2-4 antibody detection and how can they be addressed?

Researchers frequently encounter several challenges when working with GLX2-4 antibody. Here are solutions to common problems:

Challenge 1: Weak or No Signal

Potential Causes and Solutions:

  • Insufficient protein extraction: Optimize extraction buffer with 0.1-0.5% Triton X-100 or digitonin to effectively solubilize mitochondrial membranes.

  • Epitope masking: Try multiple sample preparation methods (native vs. denaturing) as protein conformation may affect antibody recognition.

  • Antibody concentration too low: Increase antibody concentration (try 1:500 instead of 1:1000) or extend incubation time to overnight at 4°C.

  • Detection system sensitivity: Switch to more sensitive detection methods such as enhanced chemiluminescence (ECL) Plus or fluorescent secondary antibodies.

  • Protein degradation: Add a comprehensive protease inhibitor cocktail immediately after sample collection and keep samples cold throughout processing.

Challenge 2: Multiple Bands or Unexpected Band Size

Potential Causes and Solutions:

  • Cross-reactivity with other GLX2 isoforms: Perform pre-adsorption with recombinant proteins of other GLX2 isoforms to improve specificity.

  • Post-translational modifications: Test phosphatase or deglycosylation treatment to determine if modifications affect band patterns.

  • Splice variants: Correlate observed bands with known splice variants of GLX2-4.

  • Protein degradation: Use freshly prepared samples and include multiple protease inhibitors in extraction buffer.

  • Different complex formation: Try native PAGE to determine if GLX2-4 forms different complexes that may separate under denaturing conditions.

Challenge 3: High Background in Immunofluorescence

Potential Causes and Solutions:

  • Autofluorescence: Include specific controls to distinguish plant autofluorescence (particularly from chlorophyll) from specific antibody signal.

  • Non-specific binding: Optimize blocking (try 5% BSA instead of milk) and include 0.1-0.3% Triton X-100 in wash buffers.

  • Overfixation: Reduce fixation time or concentration to preserve epitope accessibility.

  • Secondary antibody cross-reactivity: Test secondary antibody alone to identify non-specific binding.

  • Signal amplification issues: Consider using tyramide signal amplification for low-abundance targets while carefully controlling background.

Challenge 4: Inconsistent Immunoprecipitation Results

Potential Causes and Solutions:

  • Buffer incompatibility: Optimize salt and detergent concentrations in IP buffer to maintain antibody-antigen interaction.

  • Insufficient antibody amount: Increase antibody quantity (typically 2-5 μg per IP reaction).

  • Poor antibody binding to beads: Pre-couple antibody to beads and confirm coupling efficiency before IP.

  • Weak antibody-antigen affinity: Increase incubation time or perform crosslinking to stabilize interactions.

  • Interacting proteins masking epitope: Try alternative lysis conditions or epitope retrieval methods.

These troubleshooting approaches address the most common challenges encountered when working with GLX2-4 antibody across different experimental applications.

How can researchers address potential cross-reactivity with other glyoxalase isoforms?

Cross-reactivity with other glyoxalase isoforms is a significant concern when working with GLX2-4 antibody. Here are comprehensive strategies to address this challenge:

Experimental Assessment of Cross-Reactivity:

  • Recombinant Protein Testing: Express and purify all five GLX2 isoforms and test antibody reactivity against each using Western blot and ELISA to quantify relative binding affinities .

  • Knockout Line Validation: Test the antibody in plants with knockouts of individual GLX2 genes. Persistent signal in a GLX2-4 knockout would confirm cross-reactivity with other isoforms.

  • Peptide Competition Assays: Perform competition assays with synthetic peptides corresponding to unique regions of each GLX2 isoform to identify specific epitopes recognized by the antibody.

  • Mass Spectrometry Validation: Perform immunoprecipitation followed by mass spectrometry to identify all proteins captured by the GLX2-4 antibody.

Strategies to Mitigate Cross-Reactivity:

  • Pre-adsorption Technique:

    • Pre-incubate GLX2-4 antibody with recombinant proteins of cross-reactive isoforms.

    • Optimize pre-adsorption conditions (protein concentration, time, temperature) to maximize specificity.

    • Re-test specificity after pre-adsorption using Western blot against all isoforms.

  • Epitope-Specific Antibody Development:

    • Identify unique peptide sequences in GLX2-4 not present in other isoforms.

    • Generate new antibodies against these unique epitopes .

    • Validate specificity using recombinant proteins and knockout lines.

  • Differential Detection Strategies:

    • Exploit differences in molecular weight or isoelectric point of GLX2 isoforms using 2D gel electrophoresis.

    • Use subcellular fractionation to separate mitochondrial GLX2-4 from non-mitochondrial isoforms.

    • Combine with isoform-specific PCR to correlate protein and transcript levels.

  • Data Interpretation Approaches:

    • Always include appropriate controls to account for potential cross-reactivity.

    • Consider using relative quantification rather than absolute values when comparing samples.

    • Report potential cross-reactivity limitations transparently in publications.

  • Alternative Detection Methods:

    • Use epitope tagging of GLX2-4 in transgenic plants for highly specific detection.

    • Consider activity-based protein profiling approaches that distinguish functional differences between isoforms.

    • Develop isoform-specific activity assays to complement antibody-based detection.

By implementing these strategies, researchers can minimize the impact of cross-reactivity and generate more reliable data when studying GLX2-4 in complex plant systems.

How might emerging technologies enhance the utility of GLX2-4 antibody in plant research?

Several cutting-edge technologies show promise for expanding GLX2-4 antibody applications in plant research:

Advanced Imaging Technologies:

  • Super-resolution microscopy (STORM, PALM, STED) can reveal GLX2-4 distribution within mitochondrial substructures at nanometer resolution, providing unprecedented insights into its spatial organization .

  • Correlative light and electron microscopy (CLEM) combines the specificity of GLX2-4 immunofluorescence with ultrastructural context from electron microscopy.

  • Expansion microscopy physically enlarges specimens for enhanced resolution of GLX2-4 localization in complex subcellular environments.

Single-Cell Approaches:

  • Single-cell proteomics coupled with GLX2-4 antibody-based enrichment can reveal cell-type-specific expression patterns within heterogeneous plant tissues.

  • Mass cytometry (CyTOF) using metal-conjugated GLX2-4 antibodies enables simultaneous detection of multiple proteins across thousands of individual cells.

  • Microfluidic antibody-based sorting can isolate specific cell populations based on GLX2-4 expression levels for downstream analysis.

Proximity Labeling Technologies:

  • TurboID or miniTurbo fusions with GLX2-4 can map its protein interaction network with improved temporal resolution.

  • APEX2-based proximity labeling combined with GLX2-4 antibody validation can reveal dynamic interactomes under various stress conditions.

  • Split-BioID systems can identify condition-specific interactions between GLX2-4 and other proteins of interest.

Antibody Engineering:

  • Nanobodies against GLX2-4 offer smaller binding domains with potentially improved access to sterically hindered epitopes within mitochondria.

  • Bispecific antibodies targeting GLX2-4 and other glyoxalase components simultaneously can reveal co-localization with higher specificity.

  • Intrabodies expressed within living plant cells can track GLX2-4 dynamics in real-time.

Spatially-Resolved Transcriptomics Integration:

  • Spatial transcriptomics combined with GLX2-4 immunohistochemistry can correlate protein localization with localized gene expression profiles.

  • In situ sequencing paired with protein detection can reveal spatial relationships between GLX2-4 and its genetic regulators.

These emerging technologies will significantly enhance our understanding of GLX2-4's role in plant metabolism and stress response by providing more detailed, dynamic, and contextual information about its expression, localization, and interactions .

What are the most promising research questions that could be addressed using GLX2-4 antibody in plant stress biology?

Several high-impact research directions could be pursued using GLX2-4 antibody in plant stress biology:

  • Stress-Specific Mitochondrial Dynamics

    • How does GLX2-4 distribution within mitochondria change during different abiotic stresses?

    • Is GLX2-4 involved in stress-induced mitochondrial fission/fusion processes?

    • Does GLX2-4 relocalization correlate with changes in mitochondrial membrane potential or ROS production?

  • Integration with Energy Metabolism

    • How does GLX2-4 expression relate to mitochondrial respiratory capacity under stress?

    • What is the relationship between glycolytic flux, methylglyoxal production, and GLX2-4 protein levels?

    • Does GLX2-4 directly interact with components of oxidative phosphorylation or TCA cycle enzymes?

  • Post-Translational Regulation Mechanisms

    • What is the complete profile of stress-induced post-translational modifications on GLX2-4?

    • How do these modifications affect enzyme activity, localization, and protein interactions?

    • What are the enzymes responsible for GLX2-4 modifications, and how are they regulated?

  • Crosstalk with Other Stress Response Pathways

    • Does GLX2-4 interact with components of retrograde signaling from mitochondria to nucleus?

    • What is the relationship between GLX2-4 and plant hormone signaling pathways during stress?

    • How does GLX2-4 function integrate with antioxidant defense systems?

  • Evolutionary Adaptations in Stress Tolerance

    • How does GLX2-4 expression and function differ between stress-sensitive and stress-tolerant plant species?

    • Have specialized roles for GLX2-4 evolved in extremophile plants?

    • What structural adaptations of GLX2-4 correlate with enhanced stress tolerance?

  • Roles Beyond Canonical Glyoxalase Activity

    • Does GLX2-4 possess alternative enzymatic activities similar to the β-lactamase activity observed in GLX2-1?

    • Could GLX2-4 participate in protein lactoylation or other emerging post-translational modifications ?

    • Does GLX2-4 function as a structural component of mitochondrial protein complexes independent of its enzymatic role?

  • Translational Applications

    • Can modulation of GLX2-4 expression enhance crop tolerance to climate change-related stresses?

    • Does GLX2-4 function contribute to post-harvest stress tolerance in agricultural products?

    • Could GLX2-4 expression levels serve as a biomarker for predicting stress resilience in crop varieties?

These research directions leverage the specificity of GLX2-4 antibody to address fundamental questions in plant stress biology with significant implications for both basic science and agricultural applications .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.